GILD
Price
$98.16
Change
-$0.74 (-0.75%)
Updated
May 8 closing price
Capitalization
90.79B
88 days until earnings call
OGN
Price
$9.03
Change
+$0.26 (+2.97%)
Updated
May 8, 04:59 PM (EDT)
Capitalization
4.73B
96 days until earnings call
Ad is loading...

GILD vs OGN

Header iconGILD vs OGN Comparison
Open Charts GILD vs OGNBanner chart's image
Gilead Sciences
Price$98.16
Change-$0.74 (-0.75%)
Volume$12.99M
Capitalization90.79B
Organon & Co
Price$9.03
Change+$0.26 (+2.97%)
Volume$46.49K
Capitalization4.73B
GILD vs OGN Comparison Chart
Loading...
GILD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GILD vs. OGN commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GILD is a StrongBuy and OGN is a Hold.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (GILD: $98.16 vs. OGN: $9.02)
Brand notoriety: GILD: Notable vs. OGN: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: GILD: 130% vs. OGN: 91%
Market capitalization -- GILD: $90.79B vs. OGN: $4.73B
GILD [@Pharmaceuticals: Major] is valued at $90.79B. OGN’s [@Pharmaceuticals: Major] market capitalization is $4.73B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GILD’s FA Score shows that 2 FA rating(s) are green whileOGN’s FA Score has 2 green FA rating(s).

  • GILD’s FA Score: 2 green, 3 red.
  • OGN’s FA Score: 2 green, 3 red.
According to our system of comparison, GILD is a better buy in the long-term than OGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GILD’s TA Score shows that 3 TA indicator(s) are bullish while OGN’s TA Score has 4 bullish TA indicator(s).

  • GILD’s TA Score: 3 bullish, 7 bearish.
  • OGN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, OGN is a better buy in the short-term than GILD.

Price Growth

GILD (@Pharmaceuticals: Major) experienced а -4.93% price change this week, while OGN (@Pharmaceuticals: Major) price change was -4.55% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.19%. For the same industry, the average monthly price growth was +5.80%, and the average quarterly price growth was -6.59%.

Reported Earning Dates

GILD is expected to report earnings on Aug 05, 2025.

OGN is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-1.19% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GILD($90.8B) has a higher market cap than OGN($4.73B). GILD has higher P/E ratio than OGN: GILD (16.20) vs OGN (4.64). GILD YTD gains are higher at: 7.014 vs. OGN (-40.206). GILD has higher annual earnings (EBITDA): 10.5B vs. OGN (1.44B). GILD has more cash in the bank: 7.26B vs. OGN (693M). OGN has less debt than GILD: OGN (8.76B) vs GILD (25B). GILD has higher revenues than OGN: GILD (27.1B) vs OGN (6.26B).
GILDOGNGILD / OGN
Capitalization90.8B4.73B1,920%
EBITDA10.5B1.44B731%
Gain YTD7.014-40.206-17%
P/E Ratio16.204.64349%
Revenue27.1B6.26B433%
Total Cash7.26B693M1,048%
Total Debt25B8.76B285%
FUNDAMENTALS RATINGS
GILD: Fundamental Ratings
GILD
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
PROFIT vs RISK RATING
1..100
24
SMR RATING
1..100
87
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GILDOGN
RSI
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 2 days ago
52%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
41%
Bullish Trend 2 days ago
58%
Momentum
ODDS (%)
Bearish Trend 1 day ago
49%
Bearish Trend 2 days ago
62%
MACD
ODDS (%)
Bearish Trend 1 day ago
40%
Bearish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
48%
Bearish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
49%
Bearish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 16 days ago
58%
Bullish Trend 10 days ago
67%
Declines
ODDS (%)
Bearish Trend 3 days ago
49%
Bearish Trend 8 days ago
73%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
52%
Bullish Trend 2 days ago
57%
Aroon
ODDS (%)
Bearish Trend 1 day ago
53%
Bearish Trend 2 days ago
69%
View a ticker or compare two or three
Ad is loading...
GILD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FJP56.530.26
+0.46%
First Trust Japan AlphaDEX® ETF
NUV8.700.04
+0.46%
Nuveen Municipal Value Fund
VBND43.330.12
+0.28%
Vident U.S. Bond Strategy ETF
SOLR24.240.03
+0.13%
SmartETFs Sustainable Energy II ETF
RDFI23.06-0.01
-0.03%
Rareview Dynamic Fixed Income ETF

GILD and

Correlation & Price change

A.I.dvisor indicates that over the last year, GILD has been loosely correlated with BMY. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if GILD jumps, then BMY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GILD
1D Price
Change %
GILD100%
-0.75%
BMY - GILD
41%
Loosely correlated
-1.55%
JNJ - GILD
40%
Loosely correlated
-1.04%
PFE - GILD
37%
Loosely correlated
+0.79%
ABBV - GILD
37%
Loosely correlated
-1.33%
GSK - GILD
36%
Loosely correlated
-0.81%
More

OGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, OGN has been loosely correlated with BIIB. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if OGN jumps, then BIIB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGN
1D Price
Change %
OGN100%
-4.05%
BIIB - OGN
39%
Loosely correlated
+0.33%
LLY - OGN
39%
Loosely correlated
+0.21%
GSK - OGN
38%
Loosely correlated
-0.88%
AMGN - OGN
36%
Loosely correlated
+2.00%
NVS - OGN
34%
Loosely correlated
+1.04%
More